A novel Alzheimer disease locus located near the gene encoding tau protein

Genetic and Environmental Risk in Alzheimer's Disease (GERAD) Consortium, IGAP Consortium

Research output: Contribution to journalArticle

Abstract

APOE ε4, the most significant genetic risk factor for Alzheimer disease (AD), may mask effects of other loci. We re-analyzed genome-wide association study (GWAS) data from the International Genomics of Alzheimer's Project (IGAP) Consortium in APOE ε4+ (10 352 cases and 9207 controls) and APOE ε4- (7184 cases and 26 968 controls) subgroups as well as in the total sample testing for interaction between a single-nucleotide polymorphism (SNP) and APOE ε4 status. Suggestive associations (P<1 × 10-4) in stage 1 were evaluated in an independent sample (stage 2) containing 4203 subjects (APOE ε4+: 1250 cases and 536 controls; APOE ε4-: 718 cases and 1699 controls). Among APOE ε4- subjects, novel genome-wide significant (GWS) association was observed with 17 SNPs (all between KANSL1 and LRRC37A on chromosome 17 near MAPT) in a meta-analysis of the stage 1 and stage 2 data sets (best SNP, rs2732703, P=5·8 × 10-9). Conditional analysis revealed that rs2732703 accounted for association signals in the entire 100-kilobase region that includes MAPT. Except for previously identified AD loci showing stronger association in APOE ε4+ subjects (CR1 and CLU) or APOE ε4- subjects (MS4A6A/MS4A4A/MS4A6E), no other SNPs were significantly associated with AD in a specific APOE genotype subgroup. In addition, the finding in the stage 1 sample that AD risk is significantly influenced by the interaction of APOE with rs1595014 in TMEM106B (P=1·6 × 10-7) is noteworthy, because TMEM106B variants have previously been associated with risk of frontotemporal dementia. Expression quantitative trait locus analysis revealed that rs113986870, one of the GWS SNPs near rs2732703, is significantly associated with four KANSL1 probes that target transcription of the first translated exon and an untranslated exon in hippocampus (P≤1.3 × 10-8), frontal cortex (P≤1.3 × 10-9) and temporal cortex (P≤1.2 × 10-11). Rs113986870 is also strongly associated with a MAPT probe that targets transcription of alternatively spliced exon 3 in frontal cortex (P=9.2 × 10-6) and temporal cortex (P=2.6 × 10-6). Our APOE-stratified GWAS is the first to show GWS association for AD with SNPs in the chromosome 17q21.31 region. Replication of this finding in independent samples is needed to verify that SNPs in this region have significantly stronger effects on AD risk in persons lacking APOE ε4 compared with persons carrying this allele, and if this is found to hold, further examination of this region and studies aimed at deciphering the mechanism(s) are warranted.

Original languageEnglish (US)
Pages (from-to)108-117
Number of pages10
JournalMolecular Psychiatry
Volume21
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

tau Proteins
Single Nucleotide Polymorphism
Alzheimer Disease
Genes
Exons
Genome-Wide Association Study
Frontal Lobe
Genome
Temporal Lobe
Frontotemporal Dementia
Chromosomes, Human, Pair 17
Quantitative Trait Loci
Masks
Genomics
Meta-Analysis
Hippocampus
Chromosomes
Alleles
Genotype

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

Genetic and Environmental Risk in Alzheimer's Disease (GERAD) Consortium, & IGAP Consortium (2016). A novel Alzheimer disease locus located near the gene encoding tau protein. Molecular Psychiatry, 21(1), 108-117. https://doi.org/10.1038/mp.2015.23

A novel Alzheimer disease locus located near the gene encoding tau protein. / Genetic and Environmental Risk in Alzheimer's Disease (GERAD) Consortium; IGAP Consortium.

In: Molecular Psychiatry, Vol. 21, No. 1, 01.01.2016, p. 108-117.

Research output: Contribution to journalArticle

Genetic and Environmental Risk in Alzheimer's Disease (GERAD) Consortium & IGAP Consortium 2016, 'A novel Alzheimer disease locus located near the gene encoding tau protein', Molecular Psychiatry, vol. 21, no. 1, pp. 108-117. https://doi.org/10.1038/mp.2015.23
Genetic and Environmental Risk in Alzheimer's Disease (GERAD) Consortium, IGAP Consortium. A novel Alzheimer disease locus located near the gene encoding tau protein. Molecular Psychiatry. 2016 Jan 1;21(1):108-117. https://doi.org/10.1038/mp.2015.23
Genetic and Environmental Risk in Alzheimer's Disease (GERAD) Consortium ; IGAP Consortium. / A novel Alzheimer disease locus located near the gene encoding tau protein. In: Molecular Psychiatry. 2016 ; Vol. 21, No. 1. pp. 108-117.
@article{4c993f1cb1bb4465b6771222be5d36b3,
title = "A novel Alzheimer disease locus located near the gene encoding tau protein",
abstract = "APOE ε4, the most significant genetic risk factor for Alzheimer disease (AD), may mask effects of other loci. We re-analyzed genome-wide association study (GWAS) data from the International Genomics of Alzheimer's Project (IGAP) Consortium in APOE ε4+ (10 352 cases and 9207 controls) and APOE ε4- (7184 cases and 26 968 controls) subgroups as well as in the total sample testing for interaction between a single-nucleotide polymorphism (SNP) and APOE ε4 status. Suggestive associations (P<1 × 10-4) in stage 1 were evaluated in an independent sample (stage 2) containing 4203 subjects (APOE ε4+: 1250 cases and 536 controls; APOE ε4-: 718 cases and 1699 controls). Among APOE ε4- subjects, novel genome-wide significant (GWS) association was observed with 17 SNPs (all between KANSL1 and LRRC37A on chromosome 17 near MAPT) in a meta-analysis of the stage 1 and stage 2 data sets (best SNP, rs2732703, P=5·8 × 10-9). Conditional analysis revealed that rs2732703 accounted for association signals in the entire 100-kilobase region that includes MAPT. Except for previously identified AD loci showing stronger association in APOE ε4+ subjects (CR1 and CLU) or APOE ε4- subjects (MS4A6A/MS4A4A/MS4A6E), no other SNPs were significantly associated with AD in a specific APOE genotype subgroup. In addition, the finding in the stage 1 sample that AD risk is significantly influenced by the interaction of APOE with rs1595014 in TMEM106B (P=1·6 × 10-7) is noteworthy, because TMEM106B variants have previously been associated with risk of frontotemporal dementia. Expression quantitative trait locus analysis revealed that rs113986870, one of the GWS SNPs near rs2732703, is significantly associated with four KANSL1 probes that target transcription of the first translated exon and an untranslated exon in hippocampus (P≤1.3 × 10-8), frontal cortex (P≤1.3 × 10-9) and temporal cortex (P≤1.2 × 10-11). Rs113986870 is also strongly associated with a MAPT probe that targets transcription of alternatively spliced exon 3 in frontal cortex (P=9.2 × 10-6) and temporal cortex (P=2.6 × 10-6). Our APOE-stratified GWAS is the first to show GWS association for AD with SNPs in the chromosome 17q21.31 region. Replication of this finding in independent samples is needed to verify that SNPs in this region have significantly stronger effects on AD risk in persons lacking APOE ε4 compared with persons carrying this allele, and if this is found to hold, further examination of this region and studies aimed at deciphering the mechanism(s) are warranted.",
author = "{Genetic and Environmental Risk in Alzheimer's Disease (GERAD) Consortium} and {IGAP Consortium} and G. Jun and Ibrahim-Verbaas, {C. A.} and M. Vronskaya and Lambert, {J. C.} and J. Chung and Naj, {A. C.} and Kunkle, {B. W.} and Wang, {L. S.} and Bis, {J. C.} and C. Bellenguez and D. Harold and Lunetta, {K. L.} and Destefano, {A. L.} and B. Grenier-Boley and R. Sims and Beecham, {G. W.} and Smith, {A. V.} and V. Chouraki and Hamilton-Nelson, {K. L.} and Ikram, {M. A.} and N. Fievet and N. Denning and Martin, {E. R.} and H. Schmidt and Y. Kamatani and Dunstan, {M. L.} and O. Valladares and Laza, {A. R.} and D. Zelenika and A. Ramirez and Foroud, {T. M.} and Choi, {S. H.} and A. Boland and T. Becker and Kukull, {W. A.} and {Van Der Lee}, {S. J.} and F. Pasquier and C. Cruchaga and D. Beekly and Fitzpatrick, {A. L.} and O. Hanon and M. Gill and R. Barber and V. Gudnason and D. Campion and S. Love and Bennett, {D. A.} and Marilyn Albert and Lyketsos, {Constantine G} and Troncoso, {Juan C}",
year = "2016",
month = "1",
day = "1",
doi = "10.1038/mp.2015.23",
language = "English (US)",
volume = "21",
pages = "108--117",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - A novel Alzheimer disease locus located near the gene encoding tau protein

AU - Genetic and Environmental Risk in Alzheimer's Disease (GERAD) Consortium

AU - IGAP Consortium

AU - Jun, G.

AU - Ibrahim-Verbaas, C. A.

AU - Vronskaya, M.

AU - Lambert, J. C.

AU - Chung, J.

AU - Naj, A. C.

AU - Kunkle, B. W.

AU - Wang, L. S.

AU - Bis, J. C.

AU - Bellenguez, C.

AU - Harold, D.

AU - Lunetta, K. L.

AU - Destefano, A. L.

AU - Grenier-Boley, B.

AU - Sims, R.

AU - Beecham, G. W.

AU - Smith, A. V.

AU - Chouraki, V.

AU - Hamilton-Nelson, K. L.

AU - Ikram, M. A.

AU - Fievet, N.

AU - Denning, N.

AU - Martin, E. R.

AU - Schmidt, H.

AU - Kamatani, Y.

AU - Dunstan, M. L.

AU - Valladares, O.

AU - Laza, A. R.

AU - Zelenika, D.

AU - Ramirez, A.

AU - Foroud, T. M.

AU - Choi, S. H.

AU - Boland, A.

AU - Becker, T.

AU - Kukull, W. A.

AU - Van Der Lee, S. J.

AU - Pasquier, F.

AU - Cruchaga, C.

AU - Beekly, D.

AU - Fitzpatrick, A. L.

AU - Hanon, O.

AU - Gill, M.

AU - Barber, R.

AU - Gudnason, V.

AU - Campion, D.

AU - Love, S.

AU - Bennett, D. A.

AU - Albert, Marilyn

AU - Lyketsos, Constantine G

AU - Troncoso, Juan C

PY - 2016/1/1

Y1 - 2016/1/1

N2 - APOE ε4, the most significant genetic risk factor for Alzheimer disease (AD), may mask effects of other loci. We re-analyzed genome-wide association study (GWAS) data from the International Genomics of Alzheimer's Project (IGAP) Consortium in APOE ε4+ (10 352 cases and 9207 controls) and APOE ε4- (7184 cases and 26 968 controls) subgroups as well as in the total sample testing for interaction between a single-nucleotide polymorphism (SNP) and APOE ε4 status. Suggestive associations (P<1 × 10-4) in stage 1 were evaluated in an independent sample (stage 2) containing 4203 subjects (APOE ε4+: 1250 cases and 536 controls; APOE ε4-: 718 cases and 1699 controls). Among APOE ε4- subjects, novel genome-wide significant (GWS) association was observed with 17 SNPs (all between KANSL1 and LRRC37A on chromosome 17 near MAPT) in a meta-analysis of the stage 1 and stage 2 data sets (best SNP, rs2732703, P=5·8 × 10-9). Conditional analysis revealed that rs2732703 accounted for association signals in the entire 100-kilobase region that includes MAPT. Except for previously identified AD loci showing stronger association in APOE ε4+ subjects (CR1 and CLU) or APOE ε4- subjects (MS4A6A/MS4A4A/MS4A6E), no other SNPs were significantly associated with AD in a specific APOE genotype subgroup. In addition, the finding in the stage 1 sample that AD risk is significantly influenced by the interaction of APOE with rs1595014 in TMEM106B (P=1·6 × 10-7) is noteworthy, because TMEM106B variants have previously been associated with risk of frontotemporal dementia. Expression quantitative trait locus analysis revealed that rs113986870, one of the GWS SNPs near rs2732703, is significantly associated with four KANSL1 probes that target transcription of the first translated exon and an untranslated exon in hippocampus (P≤1.3 × 10-8), frontal cortex (P≤1.3 × 10-9) and temporal cortex (P≤1.2 × 10-11). Rs113986870 is also strongly associated with a MAPT probe that targets transcription of alternatively spliced exon 3 in frontal cortex (P=9.2 × 10-6) and temporal cortex (P=2.6 × 10-6). Our APOE-stratified GWAS is the first to show GWS association for AD with SNPs in the chromosome 17q21.31 region. Replication of this finding in independent samples is needed to verify that SNPs in this region have significantly stronger effects on AD risk in persons lacking APOE ε4 compared with persons carrying this allele, and if this is found to hold, further examination of this region and studies aimed at deciphering the mechanism(s) are warranted.

AB - APOE ε4, the most significant genetic risk factor for Alzheimer disease (AD), may mask effects of other loci. We re-analyzed genome-wide association study (GWAS) data from the International Genomics of Alzheimer's Project (IGAP) Consortium in APOE ε4+ (10 352 cases and 9207 controls) and APOE ε4- (7184 cases and 26 968 controls) subgroups as well as in the total sample testing for interaction between a single-nucleotide polymorphism (SNP) and APOE ε4 status. Suggestive associations (P<1 × 10-4) in stage 1 were evaluated in an independent sample (stage 2) containing 4203 subjects (APOE ε4+: 1250 cases and 536 controls; APOE ε4-: 718 cases and 1699 controls). Among APOE ε4- subjects, novel genome-wide significant (GWS) association was observed with 17 SNPs (all between KANSL1 and LRRC37A on chromosome 17 near MAPT) in a meta-analysis of the stage 1 and stage 2 data sets (best SNP, rs2732703, P=5·8 × 10-9). Conditional analysis revealed that rs2732703 accounted for association signals in the entire 100-kilobase region that includes MAPT. Except for previously identified AD loci showing stronger association in APOE ε4+ subjects (CR1 and CLU) or APOE ε4- subjects (MS4A6A/MS4A4A/MS4A6E), no other SNPs were significantly associated with AD in a specific APOE genotype subgroup. In addition, the finding in the stage 1 sample that AD risk is significantly influenced by the interaction of APOE with rs1595014 in TMEM106B (P=1·6 × 10-7) is noteworthy, because TMEM106B variants have previously been associated with risk of frontotemporal dementia. Expression quantitative trait locus analysis revealed that rs113986870, one of the GWS SNPs near rs2732703, is significantly associated with four KANSL1 probes that target transcription of the first translated exon and an untranslated exon in hippocampus (P≤1.3 × 10-8), frontal cortex (P≤1.3 × 10-9) and temporal cortex (P≤1.2 × 10-11). Rs113986870 is also strongly associated with a MAPT probe that targets transcription of alternatively spliced exon 3 in frontal cortex (P=9.2 × 10-6) and temporal cortex (P=2.6 × 10-6). Our APOE-stratified GWAS is the first to show GWS association for AD with SNPs in the chromosome 17q21.31 region. Replication of this finding in independent samples is needed to verify that SNPs in this region have significantly stronger effects on AD risk in persons lacking APOE ε4 compared with persons carrying this allele, and if this is found to hold, further examination of this region and studies aimed at deciphering the mechanism(s) are warranted.

UR - http://www.scopus.com/inward/record.url?scp=84948671541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948671541&partnerID=8YFLogxK

U2 - 10.1038/mp.2015.23

DO - 10.1038/mp.2015.23

M3 - Article

VL - 21

SP - 108

EP - 117

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 1

ER -